Intra-cellular therapies highlights data presentations at the american society of clinical psychopharmacology annual meeting

New york, may 23, 2024 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today highlights data presentations at the american society of clinical psychopharmacology (ascp) annual meeting being held in miami, may 28 - 31, 2024.
ITCI Ratings Summary
ITCI Quant Ranking